Duke University

This is your central portal for breaking news, the latest research and important updates from $name. Bookmark this page and check back often for updates.

Q&A: Vision training to improve athletic performance

January 16, 2020
Athletes are continually looking for ways to improve their performance and gain an advantage in training to give them a leg up on their competition. …

Key opinion leaders discuss top news from 2019

Cardiology Today, January 2020
Approximately 50% of high school students are vaping. The major product in these devices is nicotine, one of the most addicting substances known. As…
Cover Story

Systemic drugs and their ocular symptoms can complicate treatment

Ocular Surgery News U.S. Edition, January 25, 2020
Drugs that treat systemic diseases can be lifesaving, but when these drugs lead to poor ocular health or vision, the treatment paradigms can be…

Is it feasible to change the immunotherapy dose schedule for a patient in complete response?

HemOnc Today, December 25, 2019
POINT Immunotherapy represents a novel form of therapy in many ways, and it may not need to be given continuously. Currently approved checkpoint…

ASH presents Scholar Awards to fellows, junior faculty

December 22, 2019
ASH announced the recipients of its 2019 Scholar Awards. The awards — presented to hematologists in the United States and Canada who conduct…
FDA News

FDA advisory committee unanimously supports approval of tazemetostat for epithelioid sarcoma

December 18, 2019
The FDA’s Oncologic Drugs Advisory Committee, or ODAC, today voted 11-0 in favor of approval of tazemetostat for the treatment of adults with…
FDA News

FDA panel narrowly supports approval of maintenance olaparib in BRCA-mutated pancreatic cancer

December 17, 2019
An FDA panel today supported approval of olaparib as maintenance treatment for adults with deleterious or suspected deleterious germline…
FDA News

FDA approves Xtandi for metastatic castration-sensitive prostate cancer

December 17, 2019
The FDA approved enzalutamide for the treatment of metastatic castration-sensitive prostate cancer. Enzalutamide (Xtandi; Pfizer, Astellas) already…
Meeting News

Pain similar in doublet, triplet regimens for multiple myeloma

December 12, 2019
ORLANDO – The addition of venetoclax to standard of care regimens in multiple myeloma did not increase the physical burden on patients…
Meeting News

Beovu improves visual acuity in AMD, polypoidal choroidal vasculopathy

October 29, 2019
SAN FRANCISCO — Treatment with Beovu resulted in visual acuity letter gains among patients with age-related macular degeneration and polypoidal…

Breast surgeon to lead Duke Cancer Institute's clinical cancer genetics program

October 18, 2019
Carolyn Menendez, MD, FACS, has been appointed director of Duke Cancer Institute’s clinical cancer genetics program. Menendez —…
Cover Story

Catheter ablation for AF: Debate continues over benefit

Cardiology Today, October 2019
The debate on the use of catheter ablation in patients with atrial fibrillation has intensified among cardiologists after results of the anticipated…
Meeting News

Valacyclovir reduces rate of fetal CMV infection by 71%

October 9, 2019
WASHINGTON — Findings from a randomized, double-blind, placebo-controlled trial presented at IDWeek sparked hope for the use of antiviral…

Programs aim to address ‘pending and widening gap’ in palliative care workforce

August 22, 2019
The field of palliative care appears to be moving in two opposite directions. Demand for services continues to increase as more people with chronic…
Meeting NewsVideo

HOP-STEP program builds plan for 'pregnancy success' in patients with lupus

August 20, 2019
HILTON HEAD, S.C. — A program developed at Duke University called Healthy Outcomes in Pregnancy with SLE Through Education of Providers, or…
In the Journals

Little difference between fecal incontinence therapies for women

August 15, 2019
Women with fecal incontinence experience negligible differences in improvement between primary interventions including anorectal manometry-assisted…
In the Journals

Artificial intelligence models may predict pulmonary embolism risk

August 12, 2019
New data published in JAMA Network Open suggest that a machine learning algorithm may be able to accurately predict a patient’s risk for…

American Society for Radiation Oncology members receive fellow designation

August 8, 2019
American Society for Radiation Oncology designated 26 members to receive ASTRO fellow designation. The honorees will be recognized during the…

Ripcord removal after Baerveldt implantation ‘reasonable’ in some patients

Ocular Surgery News U.S. Edition, August 10, 2019
The scheduled removal of a surgically implanted ripcord in a Baerveldt glaucoma drainage device resulted in similar recovery outcomes as in patients…
Meeting News

HemOnc Today honors Next Gen Innovators

HemOnc Today, July 25, 2019
HemOnc Today held a reception at ASCO Annual Meeting to honor its third class of Next Gen Innovators. The publication’s 111 Next Gen…